Should I buy Actinium Pharmaceuticals (ATNM) - Zacks?

Should I buy Actinium Pharmaceuticals (ATNM) - Zacks?

WebActinium Pharmaceuticals, Inc. Analyst Report: Pfizer Inc. Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). Conversations - Actinium Pharmaceuticals, Inc. (ATNM) Stock Price, News, Quote … Discover historical prices for ATNM stock on Yahoo Finance. View daily, weekly or … View the basic ATNM option chain and compare options of Actinium … Actinium to Showcase First-In-Class Targeted Radiotherapies in Two … See the company profile for Actinium Pharmaceuticals, Inc. (ATNM) including … See Actinium Pharmaceuticals, Inc. (ATNM) stock analyst estimates, including … See Actinium Pharmaceuticals, Inc. (ATNM) Environment, Social and Governance … Get the detailed quarterly/annual income statement for Actinium Pharmaceuticals, … Find out the direct holders, institutional holders and mutual fund holders for … Research Reports - Actinium Pharmaceuticals, Inc. (ATNM) Stock … WebMar 23, 2024 · A high-level overview of Actinium Pharmaceuticals, Inc. (ATNM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading … cool thoughts in hindi WebFeb 7, 2024 · Currently, the analyst consensus on Actinium Pharmaceuticals is a Strong Buy with an average price target of $32.50, a 170.61% upside from current levels. In a report released today, H.C ... WebMar 25, 2024 · StockNews.com downgraded shares of Actinium Pharmaceuticals (NYSE:ATNM – Get Rating) from a hold rating to a sell rating in a report issued on Friday … cool thoughts in english WebMar 24, 2024 · Actinium Pharmaceuticals, Inc. - Hold. Zacks' proprietary data indicates that Actinium Pharmaceuticals, Inc. is currently rated as a Zacks Rank 3 and we are … WebFeb 22, 2024 · Actinium Pharmaceuticals, Inc. is a clinical-stage, biopharmaceutical company. The Company is focused on developing and commercializing targeted radiotherapies to deliver cancer-killing radiation with cellular level precision to treat patients with high unmet needs. Its clinical programs use its Antibody Warhead Enabling (AWE) … cool three letter names WebFeb 21, 2024 · While ratings are subjective and will change, the latest Actinium Pharmaceuticals ( ATNM) rating was a downgraded with a price target of $0.00 to $0.00. The current price Actinium Pharmaceuticals ...

Post Opinion